Polaryx Therapeutics, Inc.
PLYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002075320
No open-market purchases or sales by Polaryx Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $5.83M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Polaryx Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +14 vs. Q4 2025
- Shares held
- 2.27M
- +2.27M vs. Q4 2025
- Total value
- $17.1M
- +$17.1M vs. Q4 2025
- New holders
- 14
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLYX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $5.83M |
| Q1 2026 | 14 | $17.1M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Polaryx Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1,781 | $13.5K | 0.00% | +1,781 | New |
| Morgan Stanley | 5,543 | $41.9K | 0.00% | +5,543 | New |
| Vanguard Global Advisers, LLC | 6,318 | $47.8K | 0.00% | +6,318 | New |
| Squarepoint Ops LLC | 12,406 | $93.8K | 0.00% | +12,406 | New |
| UBS Group AG | 13,479 | $101.9K | 0.00% | +13,479 | New |
| Goldman Sachs Group Inc | 13,483 | $101.9K | 0.00% | +13,483 | New |
| Bank of America Corp | 25,881 | $195.7K | 0.00% | +25,881 | New |
| Northern Trust Corp | 27,987 | $211.6K | 0.00% | +27,987 | New |
| BlackRock, Inc. | 41,012 | $310.1K | 0.00% | +41,012 | New |
| State Street Corp | 58,104 | $439.3K | 0.00% | +58,104 | New |
| Vanguard Fiduciary Trust Co | 104,556 | $790.4K | 0.00% | +104,556 | New |
| Millennium Management LLC | 127,525 | $964.1K | 0.00% | +127,525 | New |
| Geode Capital Management, LLC | 170,673 | $1.29M | 0.00% | +170,673 | New |
| Vanguard Capital Management LLC | 1,658,388 | $12.5M | 0.00% | +1,658,388 | New |